{"database": "lobbying", "table": "lobbying_activities", "rows": [[1130607, "57538774-e6a6-472e-b324-2b5de466c941", "Q2", "GSK (FKA GLAXOSMITHKLINE INC.)", 16293, "GSK (FKA GLAXOSMITHKLINE INC.)", 2011, "second_quarter", "TOR", "HR 5, S 218   Help Efficient, Accessible, Low-cost, Timely Healthcare Act - provisions relating to various medical malpractice and \n                        civil  justice reforms \nHR 605, S 312   Patients Freedom to Choose Act - provisions relating to reimbursement of OTC drugs under flexible spending and\n                             health savings accounts", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 1160000, 0, 0, "2011-07-20T12:21:00.077000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1130607"], "units": {}, "query_ms": 30.254359997343272, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}